CAS 1971920-73-6

Tolebrutinib

CAS : 1971920-73-6

Tolebrutinib

Degré de pureté : ≥98%

Masse moléculaire : 455.51g/mol

Ref: 54-BUP13018

Tolebrutinib

CAS : 1971920-73-6

Tolebrutinib is an oral, selective BTK inhibitor, effective for MS research, with brain penetration and IC50s of 0.4/0.7 nM in cells.

Formule : C₂₆H₂₅N₅O₃

Degré de pureté : 98.4% - 98.82%

Couleur et forme : Solid

Masse moléculaire : 455.51

Ref: TM-T9125

Tolebrutinib

Produit contrôlé

CAS : 1971920-73-6

Formule : C₂₆H₂₅N₅O₃

Couleur et forme : Neat

Masse moléculaire : 455.51

Ref: TR-T197190

Tolebrutinib

CAS : 1971920-73-6

Tolebrutinib is an investigational drug that has been shown to have potent inhibitory activity against immune functions. This drug has a number of clinical studies in progress for the treatment of heart disease and autoimmune diseases. Tolebrutinib is being developed by Novartis as a monoclonal antibody, which binds to the target protein Bruton's tyrosine kinase and inhibits its function. The binding of tolebrutinib with the protein prevents it from phosphorylating other proteins, thereby inhibiting their function. The binding of tolebrutinib with the protein also induces reversible covalent modifications at a number of sites on the protein, which may lead to the development of resistance over time.

Formule : C₂₆H₂₅N₅O₃

Degré de pureté : Min. 95%

Masse moléculaire : 455.51 g/mol

Ref: 3D-FT179188